CytomX Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

CytomX Therapeutics is a biotechnology company based in South San Francisco, California, pursuing cancer treatments through its Probody approach. The platform relies on antibodies activated at tumor sites to potentially improve safety and efficacy in oncology, and it currently supports a pipeline of five clinical-stage programs with additional candidates in development. The company has formed collaborations to advance its technology, including a partnership with Regeneron to develop conditionally activated bispecific antibody cancer therapies.

CytomX operates within the biotechnology research industry as a mid-sized firm focused on oncology and the development of targeted therapies. It emphasizes diversity, equity, and inclusion and identifies as an equal opportunity employer. In 2026, CytomX appointed Mamata Gokhale as Senior Vice President of Regulatory Affairs, reflecting ongoing leadership development.

Sign up for free to view info

Email Format Employee directory